Myricetin ameliorates atherosclerosis in the low-density-lipoprotein receptor knockout mice by suppression of cholesterol accumulation in macrophage foam cells.

We performed en face analysis of the aorta and the results showed Myr group mice developed less atherosclerotic lesions compared to Control mice, however, the difference did not reach statistical significance (Fig. 3 a) (3.31 ± 0.67% vs 4.111 ± 0.75%, P = 0.44).

also in 111,027 other papers